Miscellaneous antifungal medications

Last updated: November 01, 2022

Miscellaneous antifungal medications

End of Rotation™ exam review

ENOT and ophthalmology

Anatomy clinical correlates: Skull, face and scalp
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Anatomy clinical correlates: Eye
Anatomy clinical correlates: Ear
Anatomy clinical correlates: Vessels, nerves and lymphatics of the neck
Anatomy clinical correlates: Viscera of the neck
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Allergic rhinitis: Clinical sciences
Approach to amblyopia and strabismus (pediatrics): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Conjunctival disorders: Clinical sciences
Croup and epiglottitis: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Antihistamines for allergies

Gastrointestinal and nutritional system

Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Peritoneum and diaphragm
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Anatomy clinical correlates: Other abdominal organs
Appendicitis: Pathology review
Congenital gastrointestinal disorders: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Jaundice: Pathology review
Malabsorption syndromes: Pathology review
Viral hepatitis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Appendicitis: Clinical sciences
Approach to abdominal wall defects: Clinical sciences
Approach to acute abdominal pain (pediatrics): Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Approach to connective tissue disorders: Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to medication exposure (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to the acute abdomen (pediatrics): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Dehydration (pediatrics): Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Infectious gastroenteritis (acute) (pediatrics): Clinical sciences
Infectious gastroenteritis (subacute) (pediatrics): Clinical sciences
Inguinal hernias: Clinical sciences
Intussusception: Clinical sciences
Pyloric stenosis: Clinical sciences
Umbilical hernias: Clinical sciences
Acid reducing medications
Antidiarrheals
Laxatives and cathartics

Neurology and developmental

Autosomal trisomies: Pathology review
Central nervous system infections: Pathology review
Disorders of sex chromosomes: Pathology review
Seizures: Pathology review
Developmental milestones (childhood): Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Immunizations (pediatrics): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Approach to a suspected brain tumor (pediatrics): Clinical sciences
Approach to aneuploidies and microdeletions: Clinical sciences
Approach to atypical genitalia: Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to neurocutaneous syndromes: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Meningitis (pediatrics): Clinical sciences
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Transcript

Watch video only

Antifungal agents are a class of medications used to treat mycoses, or fungal infections.

Mycoses can be superficial, meaning they are localized on the skin, or develop into systemic infections in immunodeficient patients.

Antifungals work either through fungistatic action, meaning that they inhibit fungal growth, or through fungicidal action, meaning they kill the fungi.

Now, antifungals include the azole family and a novel class of medications, echinocandins; but there are also many other antifungals with similar or different mechanisms that we’ll talk about in this video.

Okay, most fungal cells have a tough outer cell wall and an inner cell membrane.

The cell membrane is mostly made of phospholipids with some sterol or modified steroid molecules mixed in.

Humans have cholesterol, while fungi have ergosterol. Both sterol molecules help keep the cell membrane stable at a wide range of temperatures.

Now, the precursor to both molecules is lanosterol.

The precursor of lanosterol is squalene.

The conversion of squalene to lanosterol is catalyzed by an enzyme called squalene epoxidase.

Fungi have a cytochrome p450 enzyme called fourteen-alpha-demethylase in their mitochondria and endoplasmic reticulums, which converts lanosterol to ergosterol.

Without ergosterol, the structure of the cell membrane will be disrupted.

This will cause membrane-bound proteins, like ion channels, to stop working properly.

The membrane also becomes fragile, which eventually leads to inhibition of fungal growth.

Okay, let’s start with polyenes, which are naturally-derived antifungal antibiotics that alter cell membrane permeability.

They include amphotericin, also called amphotericin B, and nystatin.

Polyenes have both hydrophilic, meaning they love water, and lipophilic, meaning they love fats, characteristics.

They bind to ergosterol, and the hydrophilic core causes the formation of artificial pores in the cell membrane, thereby creating a leaky membrane.

This causes significant changes in ion balance including the loss of intracellular potassium.

Depending on their concentration, polyenes are either fungistatic or fungicidal.

Now, amphotericin B is one of the most important medications for the treatment of systemic mycoses. It’s used to fight systemic infections caused by Aspergillus, Blastomyces, Candida albicans, Cryptococcus, Histoplasma, and Mucor, either alone or in combination with other drugs.

However, nowadays several azoles and echinocandins are proving to be just as effective in specific systemic mycoses as amphotericin B is, with less risk of toxicity.

Amphotericin B is also used in the treatment of visceral Leishmaniasis, caused by protozoan parasites of the genus Leishmania, that presents with fever, weight loss, fatigue, anemia, and substantial swelling of the liver and spleen.

It’s usually given by slow intravenous infusion, as it is poorly absorbed by the gastrointestinal tract.

In fungal meningitis intrathecal administration, meaning injection into the spinal canal, or into the subarachnoid space, has been used, since the drug is widely distributed to all tissues except the central nervous system, or CNS, when administered intravenously.

It can also be administered locally in the treatment of mycotic corneal ulcers and keratitis.

Amphotericin is mainly eliminated via hepatic metabolism, while a small fraction is excreted through the kidneys.

Alright, now common side effects are infusion-related and include fever, chills, muscle spasms, vomiting, headache, and in more severely affected individuals, hypotension and anaphylactoid reactions.

The most serious side effect is renal toxicity which is dose dependent and can be decreased with hydration.

Anemia may also occur due to reduction of erythropoietin production from the kidneys.

Amphotericin decreases glomerular filtration rate in the majority of the patients, which improves after treatment stops, and causes renal tubular acidosis with loss of magnesium and potassium.

This can lead to hypokalemia and hypomagnesemia which often requires subsequent potassium and magnesium supplementation.

The electrolyte imbalance can cause arrythmias.

Other side effects include impaired hepatic function and intrathecal administration may cause seizures and neurotoxicity.

Next, nystatin is an antifungal agent that is only effective in the treatment of Candida infections of the skin, mucous membranes and gastrointestinal tract.

It’s used either topically for superficial infections or orally to fight gastrointestinal fungi in patients with impaired defense mechanisms.

Side effects for the oral form include gastrointestinal disturbances like nausea, abdominal pain, vomiting, and diarrhea.

Both the oral and the topical form can cause hypersensitivity reactions such as Stevens-Johnson syndrome, which is a dangerous immune-mediated condition that affects the skin and mucous membranes such as the mouth and genitals, and also rashes, itching, and burning.

Moving on to terbinafine, which is a synthetic antifungal antibiotic that alters cell membrane permeability.

Key Takeaways

There are a few different types of antifungal medications, but they all work in similar ways. Most of them work by disrupting the formation of the fungal cell wall, which eventually kills the fungus. Some common antifungal medications include azoles (such as fluconazole and itraconazole), polyenes (such as amphotericin B and nystatin), and echinocandins (such as caspofungin and anidulafungin).

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "The antifungal pipeline: a reality check" Nature Reviews Drug Discovery (2017)
  5. "Onychomycosis" Journal of the American Academy of Dermatology (2019)
  6. "New Antifungal Agents and New Formulations Against Dermatophytes" Mycopathologia (2016)